SCIENTURE HOLDINGS, INC.
NASDAQ: SCNX (Scienture Holdings, Inc.)
Kemas kini terakhir: 15 jam lalu0.415
0.03 (9.05%)
| Penutupan Terdahulu | 0.380 |
| Buka | 0.378 |
| Jumlah Dagangan | 584,702 |
| Purata Dagangan (3B) | 1,501,683 |
| Modal Pasaran | 16,841,474 |
| Harga / Pendapatan (P/E Ke hadapan) | 21.83 |
| Harga / Jualan (P/S) | 18.64 |
| Harga / Buku (P/B) | 0.230 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -34,814.94% |
| EPS Cair (TTM) | 0.660 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -58.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.70% |
| Nisbah Semasa (MRQ) | 1.05 |
| Aliran Tunai Operasi (OCF TTM) | -7.03 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.06 M |
| Pulangan Atas Aset (ROA TTM) | -14.99% |
| Pulangan Atas Ekuiti (ROE TTM) | -35.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Pharmaceutical Retailers (US) | Bercampur | Bercampur |
| Pharmaceutical Retailers (Global) | Bercampur | Bercampur | |
| Stok | Scienture Holdings, Inc. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | 0.33 |
|
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders. |
|
| Sektor | Healthcare |
| Industri | Pharmaceutical Retailers |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 32.59% |
| % Dimiliki oleh Institusi | 1.35% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Nova Wealth Management, Inc. | 30 Jun 2026 | 30 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 Tunai |
| 25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 9.50 | 2 | 157.03 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |